文献速递癫痫

癫痫母亲哺乳婴儿的抗癫痫药物暴露研究

Antiepileptic Drug Exposure in Infants of Breastfeeding Mothers With Epilepsy.
PubMed 文献 · JAMA Neurol · 2020-01-01

这项前瞻性多中心队列研究(MONEAD)纳入351名癫痫孕妇及其345名婴儿,评估哺乳婴儿的抗癫痫药物暴露。结果显示约49%婴儿药物浓度低于定量下限,婴儿/母亲浓度中位数范围为0.3%至44.2%,支持癫痫母亲在服药期间进行母乳喂养。

要点

  • 哺乳婴儿抗癫痫药物浓度显著低于母亲血药浓度。
  • 约半数婴儿药物浓度低于定量下限。
  • 研究结果支持癫痫母亲在抗癫痫药物治疗期间母乳喂养。

核心结论

  • 哺乳婴儿的抗癫痫药物血药浓度总体上显著低于母亲血药浓度,支持癫痫母亲在服药期间进行母乳喂养。

研究设计与样本

  • 前瞻性多中心队列研究(MONEAD),2012年12月至2016年10月在美国20个中心开展,纳入351名癫痫孕妇及其345名婴儿,随访至儿童6岁。

主要发现

  • 222名(64.3%)婴儿接受母乳喂养,从138名婴儿获得164对母婴匹配浓度数据。
  • 约49%的哺乳婴儿抗癫痫药物浓度低于定量下限。
  • 7种抗癫痫药物和1种代谢物的婴儿/母亲浓度中位数范围为0.3%(范围0.2%-0.9%)至44.2%(范围35.2%-125.3%)。
  • 在多元线性回归模型中,母亲浓度是与婴儿拉莫三嗪浓度显著相关的因素(Pearson相关系数0.58;P < .001),但与婴儿左乙拉西坦浓度无关。

临床怎么用

  • 根据研究结果,癫痫母亲在服用抗癫痫药物期间可以母乳喂养,但需结合个体情况评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: There is limited information on infant drug exposure via breastfeeding by mothers who are receiving antiepileptic drug therapy. OBJECTIVE: To provide direct, objective information on antiepileptic drug exposure through breast milk. DESIGN, SETTING, AND PARTICIPANTS: This prospective cohort study was conducted between December 2012 to October 2016, with follow-up in children until 6 years of age at 20 sites across the United States. Data were collected via an observational multicenter investigation (Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs [MONEAD]) of outcomes in pregnant mothers with epilepsy and their children. Pregnant women with epilepsy who were aged 14 to 45 years, had pregnancies that had progressed to less than 20 weeks' gestational age, and had measured IQ scores of more than 70 points were enrolled and followed up through pregnancy and 9 postpartum months. Their infants were enrolled at birth. Data were analyzed from May 2014 to August 2019. EXPOSURES: Antiepileptic drug exposure in infants who were breastfed. MAIN OUTCOMES AND MEASURES: The percentage of infant-to-mother concentration of antiepileptic drugs. Antiepileptic drug concentrations were quantified from blood samples collected from infants and mothers at the same visit, 5 to 20 weeks after birth. Concentrations of antiepileptic drugs in infants at less than the lower limit of quantification were assessed as half of the lower limit. Additional measures collected were the total duration of all daily breastfeeding sessions and/or the volume of pumped breast milk ingested from a bottle. RESULTS: A total of 351 women (of 865 screened and 503 eligible individuals) were enrolled, along with their 345 infants (179 female children [51.9%]; median [range] age, 13 [5-20] weeks). Of the 345 infants, 222 (64.3%) were breastfed; the data collection yielded 164 matching infant-mother concentration pairs from 138 infants. Approximately 49% of all antiepileptic drug concentrations in nursing infants were less than the lower limit of quantification. The median percentage of infant-to-mother concentration for all 7 antiepileptic drugs and 1 metabolite (carbamazepine, carbamazepine-10,11-epoxide, levetiracetam, lamotrigine, oxcarbazepine, topiramate, valproate, and zonisamide) ranged from 0.3% (range, 0.2%-0.9%) to 44.2% (range, 35.2%-125.3%). In multiple linear regression models, maternal concentration was a significant factor associated with lamotrigine concentration in infants (Pearson correlation coefficient, 0.58; P < .001) but not levetiracetam concentration in infants. CONCLUSIONS AND RELEVANCE: Overall, antiepileptic drug concentrations in blood samples of infants who were breastfed were substantially lower than maternal blood concentrations. Given the well-known benefits of breastfeeding and the prior studies demonstrating no ill effects when the mother was receiving antiepileptic drugs, these findings support the breastfeeding of infants by mothers with epilepsy who are taking antiepileptic drug therapy.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Birnbaum AK, Meador KJ, Karanam A, et al. Antiepileptic Drug Exposure in Infants of Breastfeeding Mothers With Epilepsy. JAMA Neurol. 2020. PMID: 31886825. doi:10.1001/jamaneurol.2019.4443

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。